Cabergoline Effect on Blood Sugar in Type 2 Diabetics

• Status: Unknown status
• Trial end date: 2012-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mashhad University of Medical Sciences
• Treatments: Cabergoline

Criteria

Inclusion Criteria:

• Type 2 diabetes

• HbA1C>7

Exclusion Criteria:

• HbA1C>10

• Psychiatric disorders